Brain cancer vaccine effective in some patients

Most people with the deadly brain cancer glioblastoma die less than 18 months after diagnosis. But a multicenter clinical trial of a personalized vaccine that targets the aggressive cancer has indicated improved survival rates for such patients. The study appears May 29 in the Journal of Translational Medicine.
Strasberg

Strasberg honored by American Surgical Association

Steven Strasberg, MD, the Pruett Professor of Surgery at Washington University School of Medicine in St. Louis, received the prestigious Medallion for the Advancement of Surgical Care from the American Surgical Association on April 19 in Phoenix during the group’s annual meeting.
Medical residents in anesthesia

Medical residents honored at anesthesia conference

Sixteen residents in the Washington University School of Medicine’s Department of Anesthesiology attended the annual Midwest Anesthesia Residents’ Conference in April and brought home several awards.
Ralph Dacey photo

Dacey to be honored May 24 at Bishop Lecture

Ralph G. Dacey Jr., MD, will be the honoree and keynote speaker at the 62nd annual George H. Bishop Symposium in Experimental Neurology on Thursday, May 24. The symposium, from 1:30 to 5:30 p.m., will take place in Connor Auditorium in the Farrell Learning and Teaching Center on the Medical Campus.
E. coli image

Blood type affects severity of diarrhea caused by E. coli

A new study from the School of Medicine shows that a kind of E. coli most associated with “travelers’ diarrhea” and children in underdeveloped areas of the world causes more severe disease in people with blood type A. The findings could lead to a vaccine that could potentially protect people with type A blood against the deadliest effects.